ProfileGDS4718 / 1558742_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 23% 20% 21% 12% 23% 31% 31% 16% 17% 10% 13% 18% 23% 34% 27% 20% 17% 27% 29% 43% 17% 20% 8% 14% 23% 28% 15% 40% 18% 27% 25% 37% 18% 18% 31% 20% 27% 21% 20% 19% 20% 32% 24% 28% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2483323
GSM549102patient 115, normal, homogenized [OPG study]4.1612620
GSM549104patient 119, normal, homogenized [OPG study]4.1476421
GSM549108patient 138, normal, homogenized [OPG study]3.8679812
GSM549119patient 077, normal, homogenized [OPG study]4.2705523
GSM549133patient 032, cancer, homogenized [OPG study]4.5467331
GSM549139patient 042, cancer, homogenized [OPG study]4.5530731
GSM549099patient 107, normal, homogenized [OPG study]4.0238416
GSM549109patient 139, normal, homogenized [OPG study]4.0573917
GSM549110patient 046, normal, homogenized [OPG study]3.7869810
GSM549114patient 063, normal, homogenized [OPG study]3.8647513
GSM549122patient 082, normal, homogenized [OPG study]4.0805518
GSM549134patient 033, cancer, homogenized [OPG study]4.2641523
GSM549136patient 036, cancer, homogenized [OPG study]4.6328334
GSM549140patient 044, cancer, homogenized [OPG study]4.367327
GSM549111patient 047, normal, homogenized [OPG study]4.1209920
GSM549113patient 057, normal, homogenized [OPG study]4.0019517
GSM549132patient 031, cancer, homogenized [OPG study]4.4133727
GSM549137patient 038, cancer, homogenized [OPG study]4.4681929
GSM549142patient 047, cancer, homogenized [OPG study]5.2579543
GSM549100patient 110, normal, homogenized [OPG study]4.0410817
GSM549107patient 135, normal, homogenized [OPG study]4.1013320
GSM549115patient 068, normal, homogenized [OPG study]3.699568
GSM549116patient 072, normal, homogenized [OPG study]3.9218614
GSM549120patient 078, normal, homogenized [OPG study]4.2403123
GSM549131patient 030, cancer, homogenized [OPG study]4.3949928
GSM549118patient 074, normal, homogenized [OPG study]3.9633615
GSM549129patient 027, cancer, homogenized [OPG study]5.0060740
GSM549123patient 088, normal, homogenized [OPG study]4.0791318
GSM549124patient 006, cancer, homogenized [OPG study]4.4734827
GSM549126patient 015, cancer, homogenized [OPG study]4.3071825
GSM549128patient 025, cancer, homogenized [OPG study]4.8493937
GSM549103patient 117, normal, homogenized [OPG study]4.1212618
GSM549117patient 073, normal, homogenized [OPG study]4.0658218
GSM549138patient 041, cancer, homogenized [OPG study]4.5713831
GSM549141patient 045, cancer, homogenized [OPG study]4.0972620
GSM549130patient 028, cancer, homogenized [OPG study]4.4110427
GSM549101patient 111, normal, homogenized [OPG study]4.2143521
GSM549105patient 128, normal, homogenized [OPG study]4.1487520
GSM549106patient 134, normal, homogenized [OPG study]4.0524119
GSM549112patient 048, normal, homogenized [OPG study]4.1252720
GSM549125patient 011, cancer, homogenized [OPG study]4.6616732
GSM549127patient 024, cancer, homogenized [OPG study]4.2791924
GSM549135patient 035, cancer, homogenized [OPG study]4.4065228